The More Life Company (FRA:20MP) Total Liabilities: €0.42 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is The More Life Company Total Liabilities?

The More Life Company FRA:20MP Total Liabilities is €0.42 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

The More Life Company's Total Liabilities for the quarter that ended in Mar. 2026 was €0.42 Mil.

The More Life Company's quarterly Total Liabilities increased from Sep. 2025 (€0.05 Mil) to Dec. 2025 (€0.08 Mil) and increased from Dec. 2025 (€0.08 Mil) to Mar. 2026 (€0.42 Mil).

The More Life Company's annual Total Liabilities declined from Mar. 2024 (€0.18 Mil) to Mar. 2025 (€0.14 Mil) but then increased from Mar. 2025 (€0.14 Mil) to Mar. 2026 (€0.42 Mil).


The More Life Company Total Liabilities Historical Data

* Premium members only.

The historical data trend for The More Life Company's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The More Life Company Total Liabilities Chart

The More Life Company Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial 0.30 0.40 0.18 0.14 0.42

The More Life Company Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.05 0.05 0.08 0.42

The More Life Company Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

The More Life Company's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=0.33--0.088
=0.42

The More Life Company's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=0.33--0.088
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €0.42 Mil mean?
The More Life Company (FRA:20MP) has a Total Liabilities of €0.42 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for The More Life Company and its competitors.
Is The More Life Company's Total Liabilities too high?
The More Life Company's current Total Liabilities is €0.42 Mil.
How does The More Life Company's Total Liabilities compare to ZTS?
The More Life Company's Total Liabilities of €0.42 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for The More Life Company and its competitors. The More Life Company's current Total Liabilities is €0.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The More Life Company stock overvalued right now?
The More Life Company (FRA:20MP) has a current Total Liabilities of €0.42 Mil. The current Total Liabilities is €0.42 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For The More Life Company (FRA:20MP), the current Total Liabilities is €0.42 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The More Life Company Business Description

Address 260 Edgeley Boulevard, Unit 4, Vaughan, ON, CAN, L6K 3Y4
Mountain Valley MD Holdings Inc is a Canada-based company. The firm, along with its subsidiaries, is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine, and pharmaceutical drug applications. The company actively invests in and collaborates on pioneering biotechnologies that have the potential to revolutionize the human health and wellness landscape, drive sustainable increases in plant yields and agricultural farming practices, and broadly support animal husbandry health. The Company is a biotech company focused on advancing solutions to optimize human, animal, and plant health.